Phospholipid turnover in hormone action.
D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism; D001792:Blood Platelets / Q000378:metabolism; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D002273:Carcinogens / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D000242:Cyclic AMP / Q000502:physiology; D006152:Cyclic GMP / Q000502:physiology; D003992:Dibucaine / Q000494:pharmacology; D004075:Diglycerides / Q000494:pharmacology; D004357:Drug Synergism; D004789:Enzyme Activation / Q000187:drug effects; D006728:Hormones / Q000502:physiology*; D006801:Humans; D008563:Membrane Lipids / Q000378:metabolism; D010713:Phosphatidylcholines / Q000494:pharmacology; D010714:Phosphatidylethanolamines / Q000494:pharmacology; D010716:Phosphatidylinositols / Q000494:pharmacology; D010718:Phosphatidylserines / Q000494:pharmacology; D010743:Phospholipids / Q000378:metabolism* / Q000494:pharmacology; D010750:Phosphoproteins / Q000378:metabolism; D010766:Phosphorylation; D011493:Protein Kinase C; D047428:Protein Kinase Inhibitors; D011494:Protein Kinases / Q000378:metabolism*; D013109:Sphingomyelins / Q000494:pharmacology; D013379:Substrate Specificity; D014018:Tissue Distribution
D001095:Arachidonic Acids; D002273:Carcinogens; D004075:Diglycerides; D006728:Hormones; D008563:Membrane Lipids; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D010716:Phosphatidylinositols; D010718:Phosphatidylserines; D010743:Phospholipids; D010750:Phosphoproteins; D047428:Protein Kinase Inhibitors; D013109:Sphingomyelins; D016718:Arachidonic Acid; D000001:Calcimycin; D000242:Cyclic AMP; D011494:Protein Kinases; D011493:Protein Kinase C; D006152:Cyclic GMP; D003992:Dibucaine; D002118:Calcium; D002746:Chlorpromazine